MRNS
Closed
Marinus Pharmaceuticals Inc
0.55
0.00 (0.00%)
Last Update: 11 Feb 2025 17:30:00
Yesterday: 0.55
Day's Range: 0.55 - 0.55
Send
sign up or login to leave a comment!
When Written:
6.59
Marinus Pharmaceuticals Inc is a biopharmaceutical company that develops and commercializes innovative therapeutics to treat epilepsy and neuropsychiatric disorders. The company's lead product candidate, ganaxolone, is a synthetic analog of the endogenous neurosteroid allopregnanolone and is being developed as a potential treatment for various types of epilepsy, including status epilepticus, as well as for neuropsychiatric disorders such as postpartum depression, anxiety disorders, and Fragile X syndrome. Marinus Pharmaceuticals was founded in 2003 and is headquartered in Radnor, Pennsylvania. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol MRNS.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








